27/10/2015 - 13:10
COPENHAGEN – A novel topical nonsteroidal inhibitor of phosphodiesterase-4 showed a favorable efficacy to side effect ratio in a phase II study of adolescents and adults with mild to moderate atopic...
Field of Interest: Dermatology
News Feed: Internal Medicine News - Dermatology